Australia's Genetic Tech gains on new cancer risk assessment test

Genetic Technologies

29/05/2024 05:20

** Shares of Genetic Technologies  GTG.AX  rise as much as
27.27% to A$0.14, their highest level since April 19
    ** Stock up 13.64% to A$0.015, on track for their best day
since April 10, if gains hold
    ** The molecular diagnostics co announces a risk assessment
test for breast and ovarian cancer
    ** Adds, test allows women above the age of 30 to assess
risk of cancer due to hereditary, including those with common
gene mutations, and sporadic disease.
    ** 304,151 shares changed hands by 0413, 4.5 times the
30-day average volume of shares
    ** Stock has fallen 18.52% this year, as of last close

 (Reporting by Sherin Sunny in Bengaluru)
 ((Sherin.Sunny@thomsonreuters.com))